Search Results

There are 2598 results for: content related to: Durability of peginterferon alfa-2b treatment at 5 years in patients with hepatitis B e antigen–positive chronic hepatitis B

  1. You have free access to this content
    Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C

    Intervention Review

    The Cochrane Library

    Goran Hauser, Tahany Awad, Kristian Thorlund, Davor Štimac, Mahasen Mabrouk and Christian Gluud

    Published Online : 28 FEB 2014, DOI: 10.1002/14651858.CD005642.pub3

  2. You have free access to this content
    Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C

    Intervention Review

    The Cochrane Library

    Goran Hauser, Tahany Awad, Jesper Brok, Kristian Thorlund, Davor Štimac, Mahasen Mabrouk, Christian Gluud and Lise Lotte Gluud

    Published Online : 28 FEB 2014, DOI: 10.1002/14651858.CD005441.pub3

  3. Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus

    Intervention Review

    The Cochrane Library

    Alfonso Iorio, Emanuela Marchesini, Tahany Awad and Lise Lotte Gluud

    Published Online : 20 JAN 2010, DOI: 10.1002/14651858.CD004888.pub2

  4. You have free access to this content
    Benefits and risks of interferon therapy for hepatitis B

    Hepatology

    Volume 49, Issue S5, May 2009, Pages: S103–S111, Robert Perrillo

    Version of Record online : 27 APR 2009, DOI: 10.1002/hep.22956

  5. You have free access to this content
    Pharmacodynamics of peginterferon alfa-2a and peginterferon alfa-2b in interferon-naïve patients with chronic hepatitis C: a randomized, controlled study

    Alimentary Pharmacology & Therapeutics

    Volume 26, Issue 3, August 2007, Pages: 369–376, R. BRUNO, P. SACCHI, C. SCAGNOLARI, F. TORRIANI, L. MAIOCCHI, S. PATRUNO, F. BELLOMI, G. FILICE and G. ANTONELLI

    Version of Record online : 29 MAY 2007, DOI: 10.1111/j.1365-2036.2007.03392.x

  6. You have free access to this content
    Peginterferon alfa-2a/ribavirin in hepatitis C virus patients nontolerant or nonresponsive to peginterferon alfa-2b/ribavirin

    Alimentary Pharmacology & Therapeutics

    Volume 27, Issue 5, March 2008, Pages: 433–440, V. K. RUSTGI, S. ESPOSITO, F. M. HAMZEH and M. L. SHIFFMAN

    Version of Record online : 10 DEC 2007, DOI: 10.1111/j.1365-2036.2007.03587.x

  7. You have free access to this content
    Peginterferon vs. standard interferon in the treatment of chronic hepatitis C

    Alimentary Pharmacology & Therapeutics

    Volume 18, Issue 7, October 2003, Pages: 661–670, A. Zaman, M. B. Fennerty and E. B. Keeffe

    Version of Record online : 19 SEP 2003, DOI: 10.1046/j.1365-2036.2003.01747.x

  8. Estimating the likelihood of sustained virological response in chronic hepatitis C therapy

    Journal of Viral Hepatitis

    Volume 18, Issue 4, April 2011, Pages: e81–e90, S. Mauss, D. Hueppe, C. John, J Goelz, R. Heyne, B. Moeller, R. Link, G. Teuber, A. Herrmann, M. Spelter, S. Wollschlaeger, A. Baumgarten, K.-G. Simon, N. Dikopoulos and T. Witthoeft

    Version of Record online : 16 SEP 2010, DOI: 10.1111/j.1365-2893.2010.01372.x

  9. You have free access to this content
    Randomised clinical trial: efficacy of peginterferon alfa-2a in HBeAg positive chronic hepatitis B patients with lamivudine resistance

    Alimentary Pharmacology & Therapeutics

    Volume 34, Issue 4, August 2011, Pages: 424–431, J. Sun, J.-L. Hou, Q. Xie, X.-H. Li, J.-M. Zhang, Y.-M. Wang, H. Wang, J.-Y. Lai, S.-J. Chen, J.-D. Jia, J.-F. Sheng, H. L. Y. Chan, J.-F. Wang, M. K. K. Li, M. Jiang, M. Popescu and J. J. Y. Sung

    Version of Record online : 22 JUN 2011, DOI: 10.1111/j.1365-2036.2011.04750.x

  10. You have free access to this content
    The treatment of chronic hepatitis C in HIV-infected patients: a meta-analysis

    HIV Medicine

    Volume 8, Issue 5, July 2007, Pages: 312–321, AI Kim, A Dorn, R Bouajram and S Saab

    Version of Record online : 7 JUN 2007, DOI: 10.1111/j.1468-1293.2007.00476.x

  11. Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients

    Intervention Review

    The Cochrane Library

    Lior H Katz, Hadar Goldvaser, Anat Gafter-Gvili and Ran Tur-Kaspa

    Published Online : 12 SEP 2012, DOI: 10.1002/14651858.CD008516.pub2

  12. You have free access to this content
    Nitazoxanide for chronic hepatitis C

    Intervention Review

    The Cochrane Library

    Kristiana Nikolova, Christian Gluud, Berit Grevstad and Janus C Jakobsen

    Published Online : 6 APR 2014, DOI: 10.1002/14651858.CD009182.pub2

  13. Boceprevir: A Novel NS3/4 Protease Inhibitor for the Treatment of Hepatitis C

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 32, Issue 2, February 2012, Pages: 173–190, Olga M. Klibanov, Stephen B. Vickery, Jacqueline L. Olin, Lisa S. Smith and Shannon H. Williams

    Version of Record online : 30 JAN 2012, DOI: 10.1002/PHAR.1046

  14. You have free access to this content
    Systematic review: treatment of chronic hepatitis B virus infection by pegylated interferon

    Alimentary Pharmacology & Therapeutics

    Volume 22, Issue 6, September 2005, Pages: 519–528, A. Y. HUI, H. L.-Y. CHAN, A. Y.-K. CHEUNG, G. COOKSLEY and J. J.-Y. SUNG

    Version of Record online : 13 SEP 2005, DOI: 10.1111/j.1365-2036.2005.02616.x

  15. Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 14, Issue 10, October 2007, Pages: 721–729, A. M. Di Bisceglie, R. H. Ghalib, F. M. Hamzeh and V. K. Rustgi

    Version of Record online : 26 APR 2007, DOI: 10.1111/j.1365-2893.2007.00862.x

  16. You have free access to this content
    Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis C

    Hepatology

    Volume 46, Issue 3, September 2007, Pages: 640–648, Nicole Forestier, Hendrik W. Reesink, Christine J. Weegink, Lindsay McNair, Tara L. Kieffer, Hui-May Chu, Susan Purdy, Peter L.M. Jansen and Stefan Zeuzem

    Version of Record online : 24 AUG 2007, DOI: 10.1002/hep.21774

  17. You have free access to this content
    Serum HBsAg quantification to predict response to peginterferon therapy of e antigen positive chronic hepatitis B

    Alimentary Pharmacology & Therapeutics

    Volume 32, Issue 11-12, December 2010, Pages: 1323–1331, H. L.-Y. Chan, V. W.-S. Wong, A. M.-L. Chim, H.-Y. Chan, G. L.-H. Wong and J. J.-Y. Sung

    Version of Record online : 28 SEP 2010, DOI: 10.1111/j.1365-2036.2010.04474.x

  18. You have free access to this content
    Diagnosis, management, and treatment of hepatitis C: An update

    Hepatology

    Volume 49, Issue 4, April 2009, Pages: 1335–1374, Marc G. Ghany, Doris B. Strader, David L. Thomas and Leonard B. Seeff

    Version of Record online : 2 DEC 2008, DOI: 10.1002/hep.22759

  19. Peginterferon alfa-2a and ribavirin for chronic hepatitis C genotype 1 infections in black patients: safety, tolerability and impact on sustained virologic response

    Journal of Viral Hepatitis

    Volume 13, Issue 6, June 2006, Pages: 371–376, C. D. Howell, L. S. Jeffers, W. Cassidy, K. R. Reddy, S. Hu and J. S. Lee

    Version of Record online : 3 APR 2006, DOI: 10.1111/j.1365-2893.2005.00697.x

  20. You have free access to this content
    Results of the IDEAL trial: “Mirror, mirror on the wall … Which's the fairest peg-interferon of them all?”

    Hepatology

    Volume 50, Issue 6, December 2009, Pages: 2034–2037, Julian Schulze zur Wiesch and Ansgar W. Lohse

    Version of Record online : 20 NOV 2009, DOI: 10.1002/hep.23376